Stevens-Johnson Syndrome (SJS) and toxic epidermal necrolysis (TEN) are life-threatening drug reactions that cause the skin to blister and peel. When these conditions result from negligent prescribing or inadequate warnings, patients may have legal options. The Legal Examiner covers SJS/TEN cases, drug safety developments, and the rights of patients harmed by preventable adverse reactions.
When SJS or TEN develops after taking a medication, determining who may be responsible can require examining drug warnings, prescribing decisions, medical records, and what manufacturers and healthcare providers knew about the risks.
Diagnosing Stevens-Johnson syndrome isn't always straightforward. Discover how emergency departments evaluate suspected cases, why medication history matters, and when delayed recognition may lead to questions about medical malpractice.
How do doctors decide whether a Stevens-Johnson syndrome patient needs a burn center? This article explains the medical factors that influence transfer decisions, including disease severity, complications, specialist care, and hospital resources.
One child's battle with Stevens-Johnson syndrome illustrates why early symptoms are often mistaken for common childhood illnesses and why prompt recognition can be critical.
Researchers have identified genetic markers that may help predict the risk of Stevens-Johnson syndrome for certain medications. Learn when genetic testing is recommended, its limitations, and how it may help prevent some severe drug reactions.
A delayed Stevens-Johnson syndrome diagnosis can leave children facing serious complications. Learn how pediatric SJS develops, why early symptoms are often missed, and when families may seek answers about medication risks or medical malpractice.
Many people associate Stevens-Johnson syndrome with prescription drugs, but some widely used OTC medications have also been linked to the condition. Learn which medications have been identified in reports, the symptoms to watch for, and why early treatment matters.
Stevens-Johnson syndrome often develops within weeks of starting a new prescription, but symptoms can sometimes appear within days or even after a drug has been stopped. Learn the warning signs, timeline, and why early diagnosis matters.
Studies show many SJS survivors cope with PTSD, anxiety, isolation, and emotional trauma long after leaving the hospital, highlighting the need for ongoing mental health support.
Stevens-Johnson syndrome can begin with flu-like symptoms before escalating into a life-threatening medical emergency. Understanding the early warning signs may help patients seek treatment before severe complications develop.
Children face unique SJS risks — different drug metabolism, higher misdiagnosis rates, and medications like lamotrigine and carbamazepine that carry FDA boxed warnings. Parents have legal options including extended statutes of limitations for minors.
Stevens-Johnson Syndrome is too often misdiagnosed. When a delayed diagnosis allows the drug reaction to progress, the consequences can be catastrophic — and the diagnostic failure may be medical malpractice.
